Tool Create startup animated videos in minutes, not in hours! 

Solarea Bio Announces $11.2M in Series A

Solarea Bio Announces $11.2M in Series A Back to HomeCAMBRIDGE, MA, Solarea Bio announced it has raised $11.2M in a Series A financing led by S2G Ventures. Solarea Bio, a biotech company based in Cambridge, MA developing microbial-based solutions to aid human health, announced it has raised $11.2M in a Series A financing. The round was led by S2G Ventures and Bold Capital Partners, along with continued investment from Viking Global and additional investment from the Gisev Family Office as a syndicate investor. Solarea Bio is a biotechnology company based in Cambridge, MA developing new microbiome-based solutions to some of the world's largest health problems. Solarea was founded in 2017 by a group of scientists and entrepreneurs eager to radically alter our understanding of the human microbiome and utilize its power to improve human health.

Startup Around is now on Telegram and Whatsapp. For the best startup stories & resources, subscribe us on Telegram & Whatsapp.
Get the best stories from Startup Around on Telegram